Speaker(s):
Moderator(s):
Michael M. O'Hara RPh, Centralized Clinical Pharmacy Services, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
Review transmission, disease course, and complications of measles infection
Review vaccine schedule for pediatric and adult patients
Discuss indications and pharmacotherayp for post expose prophylaxis
Review Management strategies for active infection
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Sarah F. Hale, PharmD, Daniel Longyhore, PharmD, Ed.D, BCACP, Michael M O’Hara RPh, and Mary Beth Mickel, CPhT have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None.
- 0.50 ACPE
- 0.50 ACPE Tech
- 0.50 Participation Credit

Facebook
X
LinkedIn
Forward